Sandra De Jonghe

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

Chemoprevention Strategy, Pathology, Toxicology Testing +17

Evaluation of miR-122 and Other Biomarkers in Distinct Acute Liver Injury in Rats

Sofie Starckx, Ameesha Batheja, Geert R. Verheyen et al. · Toxicologic Pathology · 2012 · 66 citations

Pathology, Oxidative Stress, Inflammation +21

The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension

Nicolas Darville, Marjolein van Heerden, Dirk Mariën et al. · Journal of Controlled Release · 2016 · 62 citations · Full text

Pharmaceutical Science, Pharmacological Study, Angiogenesis Inhibition +8

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin

Sandra De Jonghe, Jim Proctor, Petra Vinken et al. · Chemico-Biological Interactions · 2014 · 54 citations

Chemoprevention Strategy, Sglt2 Inhibitor Canagliflozin, Oncogenic Agent +6

Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat

Nicolas Darville, Marjolein van Heerden, Tim Erkens et al. · Toxicologic Pathology · 2015 · 46 citations · Full text